That comparison adds both credibility and controversy, since consumers are quick to debate whether natural supplements can deliver meaningful results
The Bottom Line: Promise Tempered by Reality Retatrutide is legitimately impressive based on current data
Vishal Khetpal is a fellow in cardiovascular disease in the Brown University Cardiology Fellowship Program
GLP-1 Examples A 2023 update 6 tells us there are currently seven GLP-1 receptor agonists, including: Exenatide Brand name: Byetta Dosage: twice-daily injection Exenatide extended-release Brand name: Bydureon Dosage: once-weekly injection Lixisenatide Brand name: Adlyxin Dosage: once-daily injection Liraglutide Brand names: Victoza and Saxenda Dosage: once-daily injection Dulaglutide Brand names: Trulicity Dosage: once-weekly injection Semaglutide Brand names: Ozempic and Wegovy Dosage: once-weekly injection Oral semaglutide Brand name: Rybelsus Dosage: once-daily injection We also can't overlook tirzepatide (branded as Mounjaro), which is the first agonist that targets both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors
Helpful strategies include: Eat small, frequent meals Even if hunger cues are reduced, try to eat regularly throughout the day
Noom brings more than 15 years of behavior-based weight management experience to its Noom Med program, which combines GLP-1 treatment with coaching, mindset support, and habit-building tools
